At Aldatu, we are applying our proprietary genotyping tech, PANDAA, to the development of diagnostic tools specifically designed to meet the clinical requirements and economic constraints of their intended use setting. By uniquely enabling an existing technology platform – qPCR – we bring its speed, sensitivity, and affordability to new diagnostic applications like HIV drug resistance testing.
- Harvard Graduate School of Arts and Sciences
- Harvard School of Public Health
- Fall 2016
- Global/Public Health
- Life/Physical Sciences
- Research Tools